IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X phase 2 clinical trial presentation, page-26

  1. 411 Posts.
    lightbulb Created with Sketch. 418
    Highly doubt it is sold through SAS. An only in class drug for OSA won’t be cheap nor should it.
    Epydilox (sorry if I have misspelt) was thousands per treatment I believe before it was out on PBS.
    Also the reason they go through FDA pathway, so government is picking up the tab.
    Also means huge margin.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.